In our highly fragmented world of information, it is impossible to discover and analyze all IP data to fully support R&D decisions. 

In the fast-paced world of pharmaceuticals, innovation is the key to success. Yet, traditional drug development processes are costly and time-consuming, often taking up to $2.6 billion and 10-14 years to bring a new drug to market. However, with the emergence of global health crises like the COVID-19 pandemic, the urgency to accelerate drug discovery has never been more evident.

With over 135 million patents published worldwide, navigating the vast corpus of information to determine the uniqueness of a compound or the complexity of its components can be daunting. This data volume explosion and increasing patent complexity turn searches into incredibly time-consuming endeavors.

At SEMANTIC INTELLIGENCE, we harness the power of cutting-edge AI technologies to revolutionize the drug discovery process.

1lfi7wkgwz4-nasa.jpg

In 2023 Semantic Intelligence was selected as award winner of the WomenTech EU grant. This program is created to boost innovation in Europe’s female-led deep-tech sector. Program is funded under the European Innovation Ecosystems work programme of Horizon Europe

eitHaccelerated_EU_2.jpg
Semantic Intelligence, LLC has signed Contracts No.IZ-L-2019/35 (on 17.06.2019) and No. IZ-L-2020/95 (on 20.03.2020) with the Latvian Investment and Development Agency on support for participation in exhibitions and conferences, as well as providing…

Semantic Intelligence, LLC has signed Contracts No.IZ-L-2019/35 (on 17.06.2019) and No. IZ-L-2020/95 (on 20.03.2020) with the Latvian Investment and Development Agency on support for participation in exhibitions and conferences, as well as providing direct visits to a potential investor or business partner abroad in the European Regional Development Fund project "Technology Transfer Program" number 1.2.1.2/16/I/001